Current Events

A federal appeals court has upheld a $28 million judgment against cigarette maker R.J. Reynolds in a lawsuit filed by a Connecticut smoker who got cancer.

A three-judge panel of the 2nd US Circuit Court of Appeals in New York also ruled Friday that the case will be sent back to the trial court to see if the company must pay additional damages.

Norwich resident Barbara Izzarelli sued the Winston-Salem, NC-based company in 1999 after surviving laryngeal cancer.
Read more . . .

A California judge has granted a preliminary approval for Wells Fargo & Co's agreement to pay $142 million, and perhaps more, to customers whose credit scores were harmed by its employees creating fake accounts in their names, the bank said on Sunday.

Wells Fargo has set aside that money to compensate customers who are part of a class-action lawsuit involving claims regarding consumer or small business bank accounts, credit cards or loans, as well as identity theft protection, between May 2002 and April of this year. It plans to begin reaching out to those affected customers soon.

In the "unlikely event" that there are so many claims, and there is not $25 million left over to distribute across all customers involved in the lawsuit, Wells Fargo said it will pay more. The bank reached the settlement in April, according to a regulatory filing, but the judge's preliminary approval moves the deal to the next step.
Read more . . .

The number of opioid prescriptions written in the United States has declined in recent years, according to newly released federal data, but the number of people who have fallen victim to fatal overdoses from prescription painkillers or heroin continues to rise.

The problem is especially acute in small town and rural America, where the unemployment rate remains high and a disproportionate number of residents are on Medicare or Medicaid, according to the data released by the Centers for Disease Control and Prevention. 

The rapid growth in opioid prescriptions in the last two decades has coincided with and contributed to a spike in the number of drug overdoses in the United States. And even as prescriptions have slumped, more people are dying: More than 52,000 people died of drug overdoses in 2015, the last full year for which data is available. 

Early estimates suggest the number of overdose deaths was far higher in 2016, and growing still in the early months of 2017.
Read more . . .

Automakers around the world likely will be stuck with billions of dollars in recall losses now that airbag supplier Takata Corp. has filed for bankruptcy.

Takata's Japanese customers will feel the most pain. Honda, Toyota and Nissan combined have earmarked more than $10 billion to cover their share of the massive global recall of defective Takata airbag inflators that can explode with deadly force.

Read more . . .

The companies that manufacture and distribute highly addictive painkillers are facing a barrage of lawsuits for the toll their product has taken on communities across the country as the worst drug epidemic in U.S. history continues to escalate.

Within the past year, at least 25 states, cities and counties have filed civil cases against manufacturers, distributors and large drugstore chains that make up the $13 billion-a-year opioid industry. In the past few weeks alone, the attorneys general for Ohio and Missouri, along with the district attorneys for three counties in Tennessee, filed suits against the industry — and the attorney general for Oklahoma filed suit on Friday.
Read more . . .

A federal judge on Friday ruled that a plaintiff suing General Motors alleging a defective ignition switch could present evidence about earlier models of the switch that were involved in fatal accidents.

Read More

Last week's Takata Corp. bankruptcy filing should shield the Japanese airbag supplier from some financial liability, but it does virtually nothing to speed the U.S. airbag inflator recall that is frustrating manufacturers and auto dealers.

Automakers say two problems in the recall, which began in 2008, continue to bedevil the industry: the ongoing need for millions of replacement parts, and figuring out how to get vehicle owners into dealerships for the free repairs.
Read more . . .

Medical device giant Medtronic PLC has told investors that the company is ready to close the book on one of its biggest and longest-running legal headaches, involving the controversial back-surgery product Infuse.

Infuse includes a genetically engineered protein that causes bones to fuse rapidly after lower back pain surgery. Thousands of patients claim the chemical was used inappropriately, causing permanent, debilitating injuries. In a securities filing Tuesday, Minnesota-run Medtronic revealed that it has reached agreements to settle “substantially all” of the 6,000 actual and threatened Infuse lawsuits.

Read more . . .

A Westchester County business “has repeatedly been contaminated” with the potentially life-threatening listeria bacterium, the Manhattan U.S. Attorney’s office says in a civil lawsuit filed Tuesday.

The Smokehouse of New York, located in Mamaroneck, has had listeria monocytogenes outbreaks due to a “persistent failure to operate their business in compliance with federal health standards,” the office alleges.

Read more . . .

Wang Jianfeng has been on an epic acquisition tear over the past decade, assembling a formidable auto parts empire in China with $4 billion in revenue.

Now, the 46-year-old Wang, founder and chairman of Ningbo Joyson Electronic Corp., is about to pull off his biggest deal yet: a $1.59 billion takeover of Takata Corp., the troubled air-bag maker that filed for bankruptcy protection on Monday and is in the midst of the largest auto recall in history.

To keep his anxiety under control, Peter, a 35-year-old government employee, relied for nine years on a blue-and-white pill he popped every night before bed: Cymbalta, made by Eli Lilly & Co. When a generic version came on the market, offering the chance to save money, he switched.

It didn’t work out. The old symptoms of anxiety resurfaced, along with some entirely new ones: “Irritability, and also it kind of felt like a blanket over your brain the whole time.” It didn’t occur to Peter to blame the medicine -- he assumed it was the same as what he’d been taking all along.